234 related articles for article (PubMed ID: 31821039)
1. Amitriptyline inhibits nonalcoholic steatohepatitis and atherosclerosis induced by high-fat diet and LPS through modulation of sphingolipid metabolism.
Lu Z; Li Y; Syn WK; Wang Z; Lopes-Virella MF; Lyons TJ; Huang Y
Am J Physiol Endocrinol Metab; 2020 Feb; 318(2):E131-E144. PubMed ID: 31821039
[TBL] [Abstract][Full Text] [Related]
2. ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis.
Fucho R; Martínez L; Baulies A; Torres S; Tarrats N; Fernandez A; Ribas V; Astudillo AM; Balsinde J; Garcia-Rovés P; Elena M; Bergheim I; Lotersztajn S; Trautwein C; Appelqvist H; Paton AW; Paton JC; Czaja MJ; Kaplowitz N; Fernandez-Checa JC; García-Ruiz C
J Hepatol; 2014 Nov; 61(5):1126-34. PubMed ID: 24946279
[TBL] [Abstract][Full Text] [Related]
3. Dietary and genetic disruption of hepatic methionine metabolism induce acid sphingomyelinase to promote steatohepatitis.
Alarcón-Vila C; Insausti-Urkia N; Torres S; Segalés-Rovira P; Conde de la Rosa L; Nuñez S; Fucho R; Fernández-Checa JC; García-Ruiz C
Redox Biol; 2023 Feb; 59():102596. PubMed ID: 36610223
[TBL] [Abstract][Full Text] [Related]
4. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
[TBL] [Abstract][Full Text] [Related]
5. The role of sphingolipid metabolism disruption on lipopolysaccharide-induced lung injury in mice.
Okuro RT; Machado MN; Casquilho NV; Jardim-Neto A; Roncally-Carvalho A; Atella GC; Zin WA
Pulm Pharmacol Ther; 2018 Jun; 50():100-110. PubMed ID: 29702255
[TBL] [Abstract][Full Text] [Related]
6. Cooperative stimulation of atherogenesis by lipopolysaccharide and palmitic acid-rich high fat diet in low-density lipoprotein receptor-deficient mice.
Lu Z; Li Y; Brinson CW; Lopes-Virella MF; Huang Y
Atherosclerosis; 2017 Oct; 265():231-241. PubMed ID: 28934649
[TBL] [Abstract][Full Text] [Related]
7. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
[TBL] [Abstract][Full Text] [Related]
8. The Presence of Periodontitis Exacerbates Non-Alcoholic Fatty Liver Disease via Sphingolipid Metabolism-Associated Insulin Resistance and Hepatic Inflammation in Mice with Metabolic Syndrome.
Lu Z; Li Y; Chowdhury N; Yu H; Syn WK; Lopes-Virella M; Yilmaz Ö; Huang Y
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176029
[TBL] [Abstract][Full Text] [Related]
9. Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
Lu Z; Li Y; Li AJ; Syn WK; Wank SA; Lopes-Virella MF; Huang Y
PLoS One; 2022; 17(11):e0277251. PubMed ID: 36331958
[TBL] [Abstract][Full Text] [Related]
10. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
11. Aucubin administration suppresses STING signaling and mitigated high-fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Liu Y; Zhang Y; Zhu H; Shen W; Chen Z; Bai J; Shuang T; Chen Q
Food Chem Toxicol; 2022 Nov; 169():113422. PubMed ID: 36108984
[TBL] [Abstract][Full Text] [Related]
12. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
[TBL] [Abstract][Full Text] [Related]
13. A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.
van den Hoek AM; Verschuren L; Worms N; van Nieuwkoop A; de Ruiter C; Attema J; Menke AL; Caspers MPM; Radhakrishnan S; Salic K; Kleemann R
Cells; 2020 Sep; 9(9):. PubMed ID: 32883049
[TBL] [Abstract][Full Text] [Related]
14. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet.
Boini KM; Zhang C; Xia M; Poklis JL; Li PL
J Pharmacol Exp Ther; 2010 Sep; 334(3):839-46. PubMed ID: 20543095
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
[TBL] [Abstract][Full Text] [Related]
16. Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism.
Montandon SA; Somm E; Loizides-Mangold U; de Vito C; Dibner C; Jornayvaz FR
Sci Rep; 2019 Nov; 9(1):16810. PubMed ID: 31728041
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhibitors of key enzymes of sphingolipid metabolism on insulin-induced glucose uptake and glycogen synthesis in liver cells of old rats.
Babenko NA; Kharchenko VS
Biochemistry (Mosc); 2015 Jan; 80(1):104-12. PubMed ID: 25754045
[TBL] [Abstract][Full Text] [Related]
18. Scoparone improves hepatic inflammation and autophagy in mice with nonalcoholic steatohepatitis by regulating the ROS/P38/Nrf2 axis and PI3K/AKT/mTOR pathway in macrophages.
Liu B; Deng X; Jiang Q; Li G; Zhang J; Zhang N; Xin S; Xu K
Biomed Pharmacother; 2020 May; 125():109895. PubMed ID: 32000066
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of acid sphingomyelinase by imipramine abolishes the synergy between metabolic syndrome and periodontitis on alveolar bone loss.
Li Y; Lu Z; Zhang L; Kirkwood CL; Kirkwood KL; Lopes-Virella MF; Huang Y
J Periodontal Res; 2022 Jan; 57(1):173-185. PubMed ID: 34748647
[TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
Lytle KA; Wong CP; Jump DB
PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
